Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

December 28, 2019

Study Completion Date

December 28, 2019

Conditions
Vasoplegic SyndromeVasoplegiaSurgery-ComplicationsSurgeryCardiovascular DiseasesCardiovascular Morbidity
Interventions
OTHER

vasoplegic syndrome

"In all included patients, 3 milliliters of venous blood will be collected before cardiopulmonary bypass, 3 milliliters of venous blood 15 minutes after the reversal of heparin with protamine and a small fragment of aortic tissue. Samples of biological material will be compared between the control and vasoplegic groups for the difference in amount and type of miRNA present.~For the diagnosis of vasospastic syndrome, the following criteria were adopted: mean arterial pressure \< 65 mmHg, cardiac index \< 2.2 L / min / m2, refractory to replacement of at least 1000 milliliters of crystalloid, excluding other causes such as tamponade, bleeding and cardiogenic shock"

Trial Locations (1)

05409011

Omar Asdrubal Vilca Mejia, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

collaborator

InCor Heart Institute

OTHER

lead

University of Sao Paulo General Hospital

OTHER

NCT05354193 - Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery | Biotech Hunter | Biotech Hunter